ImegenImegen

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • en 
  • es 
Cáncer hereditario
Customer area
  • Products and Services
    • Prenatal stage
      • Non-Invasive Prenatal Test
      • Prenatal diagnosis
      • Prenatal diagnosis of a rare disease
    • Pediatric stage
      • Neuropaediatric disorders
      • Genetic syndromes
      • Diagnosis of rare diseases
    • Adult stage
      • Diagnosis of rare diseases
      • Reproductive screening
      • Cancer
    • IMEXOME
    • Kits for analysis
  • Hospitals and Specialists
    • Kits for analysis
    • Techniques available
  • Patients and Families
    • Genetic guide
    • Non-Invasive Prenatal Test
  • R&D
    • Partner profile
    • R&D projects
  • About us
    • About us
    • Team
    • Excellent quality
HomeR&D projects

R&D projects

Below we list some of the most relevant projects in which we are currently participating:

Denamic

Developmental Neurotoxicity Assessment of Mixtures In Children:

This project aims to develop sophisticated tools and methods for the early analysis of how exposure to different neurotoxic compounds affects the health of European children

CAP

Collaborative Analytics Platforms:The aim of this project is to create a flexible platform for accessing and storing large volumes of data (big data) in real time.

Imegen contributes to this project by generating and managing genomic data and their applications in human health.

Future Clinic

The objective of the project Future Clinic is the research of methodologies and techniques required to introduce personalized genomic medicine in the health system.

Gen Clinic

Gen Clinic seeks to develop a genetic diagnosis platform based on ultrasequencing directed at simultaneous analysis of several tens of genes associated with the development of human genetic diseases.

ONCOMARKER

Design and development of an oncological biomarkers analysis platform to establish the prognosis and response to treatment in advanced or metastatic colorectal cancer. The platform will represent a complete solution fully adapted to meet the needs of genetic analysis laboratories and hospitals.

SMART-MAP

The aim of  H2020 SMART-map is to connect a wide range of industrial players with actors from research and civil society organizations and stablish innovative formats of collaboration to jointly discuss, define and implement concrete roadmaps (SMART Maps) for the responsible development of technologies and services in personalized medicine.

Customer area

I forgot my password New user Close

Instituto de Medicina Genómica, S.L.

Founded in 2009 by a team of scientists with more than 20 years’ business experience, it has since grown to become the leader in the genetics and genomics sector.

Meet Imegen

  • Products and Services
    • Prenatal stage
      • Non-Invasive Prenatal Test
      • Prenatal diagnosis
      • Prenatal diagnosis of a rare disease
    • Pediatric stage
      • Neuropaediatric disorders
      • Genetic syndromes
      • Diagnosis of rare diseases
    • Adult stage
      • Diagnosis of rare diseases
      • Reproductive screening
      • Cancer
    • IMEXOME
    • Kits for analysis
  • Hospitals and Specialists
    • Kits for analysis
    • Techniques available
  • Patients and Families
    • Genetic guide
    • Non-Invasive Prenatal Test
  • R&D
    • Partner profile
    • R&D projects
  • About us
    • About us
    • Team
    • Excellent quality

Contact

c/ Agustín Escardino 9, Parc Científic de la Universitat de València - 46980 Paterna

info@imegen.es
Tel: +34 963 212 340

Empresa cofinanciada por:
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy